{"transactions":[{"id":685273,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-17T20:05:03.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":false,"shares":24369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":11608,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":24369},"source":{"system":"sec-edgar","filing":"0001193125-26-354018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526354018/ownership.xml","form_type":"4"}},{"id":685272,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-17T20:05:03.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":false,"shares":326618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":31455,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":326618},"source":{"system":"sec-edgar","filing":"0001193125-26-354018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526354018/ownership.xml","form_type":"4"}},{"id":685271,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2026-08-17T20:05:03.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":350987,"price":10.2328,"value":3591579.7736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $10.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":62161,"source":{"system":"sec-edgar","filing":"0001193125-26-354018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526354018/ownership.xml","form_type":"4"}},{"id":685270,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2026-08-17T20:05:03.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":true,"shares":24369,"price":6.36,"value":154986.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."}],"balance_after":413148,"source":{"system":"sec-edgar","filing":"0001193125-26-354018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526354018/ownership.xml","form_type":"4"}},{"id":685269,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2026-08-17T20:05:03.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":true,"shares":326618,"price":6.36,"value":2077290.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."}],"balance_after":388779,"source":{"system":"sec-edgar","filing":"0001193125-26-354018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526354018/ownership.xml","form_type":"4"}},{"id":689025,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-12T23:41:11.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":10455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":35977,"derivative":{"exercise_price":6.36,"underlying":"Series A Common Stock","underlying_shares":10455},"source":{"system":"sec-edgar","filing":"0001193125-26-347407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/ownership.xml","form_type":"4"}},{"id":689024,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-12T23:41:11.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":9751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":358073,"derivative":{"exercise_price":6.36,"underlying":"Series A Common Stock","underlying_shares":9751},"source":{"system":"sec-edgar","filing":"0001193125-26-347407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/ownership.xml","form_type":"4"}},{"id":689023,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2026-08-12T23:41:11.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":20206,"price":9.9548,"value":201146.6888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":62161,"source":{"system":"sec-edgar","filing":"0001193125-26-347407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/ownership.xml","form_type":"4"}},{"id":689022,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2026-08-12T23:41:11.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":10455,"price":6.36,"value":66493.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."}],"balance_after":82367,"source":{"system":"sec-edgar","filing":"0001193125-26-347407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/ownership.xml","form_type":"4"}},{"id":689021,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2026-08-12T23:41:11.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":9751,"price":6.36,"value":62016.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."}],"balance_after":71912,"source":{"system":"sec-edgar","filing":"0001193125-26-347407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/ownership.xml","form_type":"4"}},{"id":704611,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Stock","published_at":"2026-07-22T20:05:03.000Z","date":"2026-07-20","kind":"sale","planned":true,"acquired":false,"shares":18844,"price":7.4575,"value":140529.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.17 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":62161,"source":{"system":"sec-edgar","filing":"0001193125-26-312386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526312386/ownership.xml","form_type":"4"}},{"id":737526,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:20:22.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":39567,"derivative":{"exercise_price":6.48,"expiration_date":"2036-06-11","underlying":"Series A Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0001104659-26-074045","document":"tm2617570-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926074045/tm2617570-2_4seq1.xml","form_type":"4"}},{"id":991098,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series A Common Stock","published_at":"2025-11-21T23:13:11.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":37688,"price":7.6942,"value":289979.0096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.27 to $8.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":81005,"source":{"system":"sec-edgar","filing":"0001104659-25-115071","document":"tm2531988-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925115071/tm2531988-1_4seq1.xml","form_type":"4"}},{"id":1116042,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-10T21:40:13.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":32250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":32250,"derivative":{"exercise_price":5.33,"expiration_date":"2035-06-08","underlying":"Series A Common Stock","underlying_shares":32250},"source":{"system":"sec-edgar","filing":"0001104659-25-058223","document":"tm2517621-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925058223/tm2517621-4_4seq1.xml","form_type":"4"}},{"id":1448603,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series A Common Stock","published_at":"2024-07-25T20:05:09.000Z","date":"2024-07-23","kind":"sale","planned":true,"acquired":false,"shares":23625,"price":3.1674,"value":74829.825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.07 to $3.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":118693,"source":{"system":"sec-edgar","filing":"0001104659-24-082630","document":"tm2420121-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924082630/tm2420121-1_4seq1.xml","form_type":"4"}},{"id":1449838,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series A Common Stock","published_at":"2024-07-23T20:05:09.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":14062,"price":3.1009,"value":43604.8558,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":142318,"source":{"system":"sec-edgar","filing":"0001104659-24-081887","document":"tm2420000-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924081887/tm2420000-1_4.xml","form_type":"4"}},{"id":1732349,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series A Common Stock","published_at":"2023-11-21T21:22:35.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":150750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. 25% of the RSUs shall vest on July 18, 2024, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":156380,"source":{"system":"sec-edgar","filing":"0001104659-23-120374","document":"tm2331048-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923120374/tm2331048-2_4seq1.xml","form_type":"4"}},{"id":1784508,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-08T20:15:41.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":false,"shares":5630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0.79,"expiration_date":"2023-09-26","underlying":"Series A Common Stock","underlying_shares":5630},"source":{"system":"sec-edgar","filing":"0001104659-23-099310","document":"tm2325723-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923099310/tm2325723-1_4seq1.xml","form_type":"4"}},{"id":1784507,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series A Common Stock","published_at":"2023-09-08T20:15:41.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":true,"shares":5630,"price":0.79,"value":4447.7,"ownership":{"direct":true},"balance_after":5630,"source":{"system":"sec-edgar","filing":"0001104659-23-099310","document":"tm2325723-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923099310/tm2325723-1_4seq1.xml","form_type":"4"}},{"id":1825563,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":21173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares underlying this option shall vest and become exercisable on October 17, 2023, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":21173,"derivative":{"exercise_price":7.15,"expiration_date":"2032-10-16","underlying":"Series A Common Stock","underlying_shares":21173},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825562,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares underlying this option shall vest and become exercisable on October 17, 2023, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.15,"expiration_date":"2032-10-16","underlying":"Common Stock","underlying_shares":21173},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825561,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":526332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest and become exercisable in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":526332,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Series A Common Stock","underlying_shares":526332},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825560,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":526332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest and become exercisable in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":526332},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825559,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":46432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":46432,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":46432},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825558,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Common Stock","underlying_shares":46432},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825557,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":367824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":367824,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":367824},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825556,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":367824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Common Stock","underlying_shares":367824},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825555,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":26352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":26352,"derivative":{"exercise_price":19.87,"expiration_date":"2025-10-12","underlying":"Series A Common Stock","underlying_shares":26352},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825554,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":19.87,"expiration_date":"2025-10-12","underlying":"Common Stock","underlying_shares":26352},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825553,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":7147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":7147,"derivative":{"exercise_price":23.05,"expiration_date":"2024-12-16","underlying":"Series A Common Stock","underlying_shares":7147},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825552,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":23.05,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":7147},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825551,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":3179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":3179,"derivative":{"exercise_price":11.13,"expiration_date":"2024-03-12","underlying":"Series A Common Stock","underlying_shares":3179},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825550,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":11.13,"expiration_date":"2024-03-12","underlying":"Common Stock","underlying_shares":3179},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825549,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":5630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":5630,"derivative":{"exercise_price":0.79,"expiration_date":"2023-09-26","underlying":"Series A Common Stock","underlying_shares":5630},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}},{"id":1825548,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":22811,"kind":"person","name":"Kemble George","position":1,"cik":"0001858176","reported_name":"Kemble George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:17:00.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0.79,"expiration_date":"2023-09-26","underlying":"Common Stock","underlying_shares":5630},"source":{"system":"sec-edgar","filing":"0001104659-23-082726","document":"tm2321276-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082726/tm2321276-16_4seq1.xml","form_type":"4"}}]}